|

YTS109 cell injection Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • China Immunotech (Beijing) Biotechnology Co., Ltd.1

Indications

  • Immune Thrombocytopenia (ITP)1
  • Lupus Nephritis (LN)1
  • Lupus1

Other1 trial

A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.